Sundar Jagannath, M.D. Director of the Multiple Myeloma Program and Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute Discusses Daratumumab In New MM Patients, Role Of CAR-T Cells At The 60th ASH Annual Meeting on Dec 1, 2018.
